Exercise‐induced liver chemokine CXCL‐1 expression is linked to muscle‐derived interleukin‐6 expression

Non‐technical summary  Exercise is known to stimulate the production of various exercise factors including the well‐described muscle‐derived interleukin‐6 (IL‐6). We show that exercise causes a massive expression of the chemokine CXCL‐1 in serum, in skeletal muscle and especially in the liver. Furth...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of physiology Vol. 589; no. 6; pp. 1409 - 1420
Main Authors Pedersen, Line, Pilegaard, Henriette, Hansen, Jakob, Brandt, Claus, Adser, Helle, Hidalgo, Juan, Olesen, Jesper, Pedersen, Bente Klarlund, Hojman, Pernille
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 15.03.2011
Wiley Subscription Services, Inc
Blackwell Science Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Non‐technical summary  Exercise is known to stimulate the production of various exercise factors including the well‐described muscle‐derived interleukin‐6 (IL‐6). We show that exercise causes a massive expression of the chemokine CXCL‐1 in serum, in skeletal muscle and especially in the liver. Furthermore we find that this exercise‐induced liver CXCL‐1 expression is regulated by IL‐6 and that muscle‐derived IL‐6 is capable of stimulating liver CXCL‐1 expression. Such knowledge of the regulation of exercise factors contributes to the understanding of how the liver and muscle communicate in response to exercise.   The chemokine CXC ligand‐1 (CXCL‐1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL‐1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL‐1 is regulated by exercise in mice. After a single bout of exercise, CXCL‐1 protein increased in serum (2.4‐fold), and CXCL‐1 mRNA in muscle (6.5‐fold) and liver (41‐fold). These increases in CXCL‐1 were preceded by increases in serum interleukin‐6 (IL‐6) and muscle IL‐6 mRNA. In contrast, exercise‐induced regulation of liver CXCL‐1 mRNA expression was completely blunted in IL‐6 knockout mice. Based on these findings, we examined the possible existence of a muscle‐to‐liver axis by overexpressing IL‐6 in muscles. This resulted in increases in serum CXCL‐1 (5‐fold) and liver CXCL‐1 mRNA expression (24‐fold) compared with control. Because IL‐6 expression and release are known to be augmented during exercise in glycogen‐depleted animals, CXCL‐1 and IL‐6 expression were examined after exercise in overnight‐fasted mice. We found that fasting significantly augmented serum CXCL‐1, and CXCL‐1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL‐1 during exercise in mice, and that the CXCL‐1 expression in the liver is regulated by muscle‐derived IL‐6.
AbstractList The aim of this study was to unravel the mechanisms whereby CXCL-1 is regulated by exercise in mice. After a single bout of exercise, CXCL-1 protein increased in serum (2.4-fold), and CXCL-1 mRNA in muscle (6.5-fold) and liver (41-fold). These increases in CXCL-1 were preceded by increases in serum interleukin-6 (IL-6) and muscle IL-6 mRNA. In contrast, exercise-induced regulation of liver CXCL-1 mRNA expression was completely blunted in IL-6 knockout mice. Based on these findings, we examined the possible existence of a muscle-to-liver axis by overexpressing IL-6 in muscles. This resulted in increases in serum CXCL-1 (5-fold) and liver CXCL-1 mRNA expression (24-fold) compared with control. Because IL-6 expression and release are known to be augmented during exercise in glycogen-depleted animals, CXCL-1 and IL-6 expression were examined after exercise in overnight-fasted mice. We found that fasting significantly augmented serum CXCL-1, and CXCL-1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL-1 during exercise in mice, and that the CXCL-1 expression in the liver is regulated by muscle-derived IL-6.
Non‐technical summary  Exercise is known to stimulate the production of various exercise factors including the well‐described muscle‐derived interleukin‐6 (IL‐6). We show that exercise causes a massive expression of the chemokine CXCL‐1 in serum, in skeletal muscle and especially in the liver. Furthermore we find that this exercise‐induced liver CXCL‐1 expression is regulated by IL‐6 and that muscle‐derived IL‐6 is capable of stimulating liver CXCL‐1 expression. Such knowledge of the regulation of exercise factors contributes to the understanding of how the liver and muscle communicate in response to exercise. Abstract  The chemokine CXC ligand‐1 (CXCL‐1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL‐1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL‐1 is regulated by exercise in mice. After a single bout of exercise, CXCL‐1 protein increased in serum (2.4‐fold), and CXCL‐1 mRNA in muscle (6.5‐fold) and liver (41‐fold). These increases in CXCL‐1 were preceded by increases in serum interleukin‐6 (IL‐6) and muscle IL‐6 mRNA. In contrast, exercise‐induced regulation of liver CXCL‐1 mRNA expression was completely blunted in IL‐6 knockout mice. Based on these findings, we examined the possible existence of a muscle‐to‐liver axis by overexpressing IL‐6 in muscles. This resulted in increases in serum CXCL‐1 (5‐fold) and liver CXCL‐1 mRNA expression (24‐fold) compared with control. Because IL‐6 expression and release are known to be augmented during exercise in glycogen‐depleted animals, CXCL‐1 and IL‐6 expression were examined after exercise in overnight‐fasted mice. We found that fasting significantly augmented serum CXCL‐1, and CXCL‐1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL‐1 during exercise in mice, and that the CXCL‐1 expression in the liver is regulated by muscle‐derived IL‐6.
The chemokine CXC ligand-1 (CXCL-1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL-1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL-1 is regulated by exercise inmice. After a single bout of exercise, CXCL-1 protein increased in serum(2.4-fold), and CXCL-1 mRNA in muscle (6.5-fold) and liver (41-fold). These increases in CXCL-1 were preceded by increases in serum interleukin-6 (IL-6) and muscle IL-6 mRNA. In contrast, exercise-induced regulation of liver CXCL-1 mRNA expression was completely blunted in IL-6 knockout mice. Based on these findings, we examined the possible existence of a muscle-to-liver axis by overexpressing IL-6 in muscles. This resulted in increases in serum CXCL-1 (5-fold) and liver CXCL-1 mRNA expression (24-fold) compared with control. Because IL-6 expression and release are known to be augmented during exercise in glycogen-depleted animals, CXCL-1 and IL-6 expression were examined after exercise in overnight-fasted mice.We found that fasting significantly augmented serum CXCL-1, and CXCL-1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL-1 during exercise in mice, and that the CXCL-1 expression in the liver is regulated by muscle-derived IL-6.
Non‐technical summary  Exercise is known to stimulate the production of various exercise factors including the well‐described muscle‐derived interleukin‐6 (IL‐6). We show that exercise causes a massive expression of the chemokine CXCL‐1 in serum, in skeletal muscle and especially in the liver. Furthermore we find that this exercise‐induced liver CXCL‐1 expression is regulated by IL‐6 and that muscle‐derived IL‐6 is capable of stimulating liver CXCL‐1 expression. Such knowledge of the regulation of exercise factors contributes to the understanding of how the liver and muscle communicate in response to exercise.   The chemokine CXC ligand‐1 (CXCL‐1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL‐1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL‐1 is regulated by exercise in mice. After a single bout of exercise, CXCL‐1 protein increased in serum (2.4‐fold), and CXCL‐1 mRNA in muscle (6.5‐fold) and liver (41‐fold). These increases in CXCL‐1 were preceded by increases in serum interleukin‐6 (IL‐6) and muscle IL‐6 mRNA. In contrast, exercise‐induced regulation of liver CXCL‐1 mRNA expression was completely blunted in IL‐6 knockout mice. Based on these findings, we examined the possible existence of a muscle‐to‐liver axis by overexpressing IL‐6 in muscles. This resulted in increases in serum CXCL‐1 (5‐fold) and liver CXCL‐1 mRNA expression (24‐fold) compared with control. Because IL‐6 expression and release are known to be augmented during exercise in glycogen‐depleted animals, CXCL‐1 and IL‐6 expression were examined after exercise in overnight‐fasted mice. We found that fasting significantly augmented serum CXCL‐1, and CXCL‐1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL‐1 during exercise in mice, and that the CXCL‐1 expression in the liver is regulated by muscle‐derived IL‐6.
Non-technical summary Exercise is known to stimulate the production of various exercise factors including the well-described muscle-derived interleukin-6 (IL-6). We show that exercise causes a massive expression of the chemokine CXCL-1 in serum, in skeletal muscle and especially in the liver. Furthermore we find that this exercise-induced liver CXCL-1 expression is regulated by IL-6 and that muscle-derived IL-6 is capable of stimulating liver CXCL-1 expression. Such knowledge of the regulation of exercise factors contributes to the understanding of how the liver and muscle communicate in response to exercise. Abstract The chemokine CXC ligand-1 (CXCL-1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL-1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL-1 is regulated by exercise in mice. After a single bout of exercise, CXCL-1 protein increased in serum (2.4-fold), and CXCL-1 mRNA in muscle (6.5-fold) and liver (41-fold). These increases in CXCL-1 were preceded by increases in serum interleukin-6 (IL-6) and muscle IL-6 mRNA. In contrast, exercise-induced regulation of liver CXCL-1 mRNA expression was completely blunted in IL-6 knockout mice. Based on these findings, we examined the possible existence of a muscle-to-liver axis by overexpressing IL-6 in muscles. This resulted in increases in serum CXCL-1 (5-fold) and liver CXCL-1 mRNA expression (24-fold) compared with control. Because IL-6 expression and release are known to be augmented during exercise in glycogen-depleted animals, CXCL-1 and IL-6 expression were examined after exercise in overnight-fasted mice. We found that fasting significantly augmented serum CXCL-1, and CXCL-1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL-1 during exercise in mice, and that the CXCL-1 expression in the liver is regulated by muscle-derived IL-6.
The chemokine CXC ligand-1 (CXCL-1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL-1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL-1 is regulated by exercise inmice. After a single bout of exercise, CXCL-1 protein increased in serum(2.4-fold), and CXCL-1 mRNA in muscle (6.5-fold) and liver (41-fold). These increases in CXCL-1 were preceded by increases in serum interleukin-6 (IL-6) and muscle IL-6 mRNA. In contrast, exercise-induced regulation of liver CXCL-1 mRNA expression was completely blunted in IL-6 knockout mice. Based on these findings, we examined the possible existence of a muscle-to-liver axis by overexpressing IL-6 in muscles. This resulted in increases in serum CXCL-1 (5-fold) and liver CXCL-1 mRNA expression (24-fold) compared with control. Because IL-6 expression and release are known to be augmented during exercise in glycogen-depleted animals, CXCL-1 and IL-6 expression were examined after exercise in overnight-fasted mice.We found that fasting significantly augmented serum CXCL-1, and CXCL-1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL-1 during exercise in mice, and that the CXCL-1 expression in the liver is regulated by muscle-derived IL-6.The chemokine CXC ligand-1 (CXCL-1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL-1 has neutrophil chemoattractant activity, is involved in the processes of angiogenesis, inflammation and wound healing, and may possess neuroprotective effects. The aim of this study was to unravel the mechanisms whereby CXCL-1 is regulated by exercise inmice. After a single bout of exercise, CXCL-1 protein increased in serum(2.4-fold), and CXCL-1 mRNA in muscle (6.5-fold) and liver (41-fold). These increases in CXCL-1 were preceded by increases in serum interleukin-6 (IL-6) and muscle IL-6 mRNA. In contrast, exercise-induced regulation of liver CXCL-1 mRNA expression was completely blunted in IL-6 knockout mice. Based on these findings, we examined the possible existence of a muscle-to-liver axis by overexpressing IL-6 in muscles. This resulted in increases in serum CXCL-1 (5-fold) and liver CXCL-1 mRNA expression (24-fold) compared with control. Because IL-6 expression and release are known to be augmented during exercise in glycogen-depleted animals, CXCL-1 and IL-6 expression were examined after exercise in overnight-fasted mice.We found that fasting significantly augmented serum CXCL-1, and CXCL-1 expression in liver and muscle. Taken together, these data indicate that liver is the main source of serum CXCL-1 during exercise in mice, and that the CXCL-1 expression in the liver is regulated by muscle-derived IL-6.
Author Adser, Helle
Pilegaard, Henriette
Hidalgo, Juan
Hansen, Jakob
Pedersen, Bente Klarlund
Brandt, Claus
Pedersen, Line
Hojman, Pernille
Olesen, Jesper
Author_xml – sequence: 1
  givenname: Line
  surname: Pedersen
  fullname: Pedersen, Line
– sequence: 2
  givenname: Henriette
  surname: Pilegaard
  fullname: Pilegaard, Henriette
– sequence: 3
  givenname: Jakob
  surname: Hansen
  fullname: Hansen, Jakob
– sequence: 4
  givenname: Claus
  surname: Brandt
  fullname: Brandt, Claus
– sequence: 5
  givenname: Helle
  surname: Adser
  fullname: Adser, Helle
– sequence: 6
  givenname: Juan
  surname: Hidalgo
  fullname: Hidalgo, Juan
– sequence: 7
  givenname: Jesper
  surname: Olesen
  fullname: Olesen, Jesper
– sequence: 8
  givenname: Bente Klarlund
  surname: Pedersen
  fullname: Pedersen, Bente Klarlund
– sequence: 9
  givenname: Pernille
  surname: Hojman
  fullname: Hojman, Pernille
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21224226$$D View this record in MEDLINE/PubMed
BookMark eNqNkstu1DAUhi1URKeFN0AoEgvYpPiWxGGBhEblppFgUSR2lmufMJ4m9tROSmfHI_CMPAlnNB1UugA2tnT8_f_xuRyRgxADEPKY0RPGmHixWi832cf-hFMMcUobIe6RGZN1WzZNKw7IjFLOS9FU7JAc5byilAnatg_IIWecS87rGYmn15Csz_Dz-w8f3GTBFb2_glTYJQzxwgco5l_mC3xmBVyvE2RMGgqfEQsXSI-xGKZs-62Dg4RaV_gwQuphQjlG61vCh-R-Z_oMj27uY_L5zenZ_F25-Pj2_fz1orSVkrLk58pZZl0npK1sRTsllDJdLVvWOCpMXTe8ahV3FdZhpGioUUJ0DiS10nVUHJNXO9_1dD6AsxDGZHq9Tn4waaOj8frPl-CX-mu80oIqzujW4NmNQYqXE-RRDz5b6HsTIE5ZqxpbLgXnSD7_K8lwClWNB0P06R10FacUsBGaVbISQrRKIfXk9t9_f3o_NQRe7gCbYs4JOm39aEZsL5bie8yotyui9yuityuidyuCYnlHvPf_h6zdyb75Hjb_pdFnHz7haKT4BTn22SQ
CODEN JPHYA7
CitedBy_id crossref_primary_10_1007_s00223_013_9813_8
crossref_primary_10_3390_ijms19123836
crossref_primary_10_3390_ijms18010008
crossref_primary_10_1152_ajpregu_00373_2016
crossref_primary_10_4103_ijpvm_ijpvm_79_24
crossref_primary_10_1152_ajpregu_00533_2013
crossref_primary_10_3390_nu11071496
crossref_primary_10_3390_metabo13090979
crossref_primary_10_1134_S0022093021040141
crossref_primary_10_3389_fphys_2021_709039
crossref_primary_10_1016_j_jtherbio_2021_102930
crossref_primary_10_1007_s00421_014_3031_6
crossref_primary_10_1111_apha_12975
crossref_primary_10_1371_journal_pone_0092505
crossref_primary_10_1039_C8LC00686E
crossref_primary_10_3390_cancers13153820
crossref_primary_10_1016_j_cyto_2017_11_006
crossref_primary_10_1016_j_exger_2015_09_020
crossref_primary_10_1038_nrendo_2012_49
crossref_primary_10_1371_journal_pone_0041719
crossref_primary_10_1016_j_cyto_2012_11_027
crossref_primary_10_1152_ajpendo_00339_2011
crossref_primary_10_1016_j_jare_2022_08_019
crossref_primary_10_1111_j_1748_1716_2011_02373_x
crossref_primary_10_1016_j_gendis_2015_10_001
crossref_primary_10_3389_fphys_2022_981577
crossref_primary_10_1371_journal_pone_0084910
crossref_primary_10_3390_ijms23084205
crossref_primary_10_1080_10715762_2017_1291942
crossref_primary_10_3390_jfmk2040035
crossref_primary_10_1139_h11_076
crossref_primary_10_14341_osteo2016128_34
crossref_primary_10_1111_bpa_12071
crossref_primary_10_3390_toxins9070197
crossref_primary_10_1113_expphysiol_2012_068726
crossref_primary_10_14814_phy2_12788
crossref_primary_10_1113_jphysiol_2012_245548
crossref_primary_10_14814_phy2_13519
crossref_primary_10_3390_nu15071729
crossref_primary_10_1016_j_biomaterials_2019_119416
crossref_primary_10_4161_adip_20344
crossref_primary_10_1007_s11010_015_2351_0
crossref_primary_10_1007_s12010_023_04755_9
crossref_primary_10_1016_j_jbc_2022_102686
crossref_primary_10_1016_j_jnutbio_2018_12_003
crossref_primary_10_1007_s00424_019_02332_w
crossref_primary_10_7717_peerj_4446
Cites_doi 10.1016/j.cyto.2010.05.002
10.1210/jc.2002-021687
10.1189/jlb.72.1.9
10.2353/ajpath.2009.080350
10.1023/A:1026070911202
10.1016/S0165-5728(99)00266-0
10.1096/fj.06-7301com
10.1096/fj.01-0507fje
10.1038/labinvest.3700435
10.1152/jappl.1997.82.5.1662
10.1152/physrev.90100.2007
10.1113/jphysiol.2004.077610
10.1079/PNS2004338
10.1007/s00125-010-1666-3
10.1155/2010/520258
10.1084/jem.180.6.2039
10.1152/ajpendo.90280.2008
10.1152/japplphysiol.00739.2009
10.1113/expphysiol.2006.034769
10.1074/mcp.M110.002113
10.1038/368339a0
10.1111/j.1432-1033.1988.tb14383.x
10.1016/j.tips.2007.02.002
10.1038/sj.gt.3302951
10.1016/j.virol.2006.08.003
10.1016/S0021-9258(19)84972-4
10.4049/jimmunol.165.9.5269
10.1111/j.1469-7793.2001.00633.x
10.1210/jc.2004-0603
10.1172/JCI37480
ContentType Journal Article
Copyright 2011 The Authors. Journal compilation © 2011 The Physiological Society
Journal compilation © 2011 The Physiological Society 2011
Copyright_xml – notice: 2011 The Authors. Journal compilation © 2011 The Physiological Society
– notice: Journal compilation © 2011 The Physiological Society 2011
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7TK
7TS
8FD
FR3
P64
7X8
5PM
DOI 10.1113/jphysiol.2010.200733
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Physical Education Index
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Physical Education Index
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Physical Education Index
CrossRef
MEDLINE

Technology Research Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1469-7793
EndPage 1420
ExternalDocumentID PMC3082100
3374326911
21224226
10_1113_jphysiol_2010_200733
TJP4374
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
-DZ
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
0YM
10A
123
18M
1OB
1OC
24P
29L
2WC
31~
33P
36B
3EH
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAFWJ
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAYJJ
AAZKR
ABCQN
ABCUV
ABEML
ABITZ
ABIVO
ABJNI
ABOCM
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOIJS
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C1A
C45
CAG
CHEAL
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FA8
FIJ
FUBAC
G-S
G.N
GODZA
GX1
H.X
H13
HF~
HGLYW
HZI
HZ~
H~9
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NEJ
NF~
O66
O9-
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
RIG
ROL
RPM
RX1
SAMSI
SUPJJ
TEORI
TLM
TN5
TR2
UB1
UKR
UPT
V8K
VH1
W8F
W8V
W99
WBKPD
WH7
WHG
WIH
WIJ
WIK
WIN
WNSPC
WOHZO
WOQ
WOW
WQJ
WRC
WXI
WXSBR
WYISQ
X7M
XG1
XOL
YBU
YHG
YKV
YQT
YSK
YXB
YYP
YZZ
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7TK
7TS
8FD
FR3
P64
7X8
5PM
ID FETCH-LOGICAL-c5844-2b8dc1cdf34c5c50f8388af64917d03a66725982d5242a4370a833fde40c4df03
IEDL.DBID DR2
ISSN 0022-3751
1469-7793
IngestDate Thu Aug 21 13:59:51 EDT 2025
Fri Jul 11 15:05:39 EDT 2025
Fri Jul 11 02:35:22 EDT 2025
Fri Jul 25 12:11:38 EDT 2025
Wed Feb 19 01:48:22 EST 2025
Tue Jul 01 04:29:00 EDT 2025
Thu Apr 24 23:08:11 EDT 2025
Wed Jan 22 17:09:07 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5844-2b8dc1cdf34c5c50f8388af64917d03a66725982d5242a4370a833fde40c4df03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/3082100
PMID 21224226
PQID 1545333988
PQPubID 1086388
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3082100
proquest_miscellaneous_862004322
proquest_miscellaneous_1022560221
proquest_journals_1545333988
pubmed_primary_21224226
crossref_citationtrail_10_1113_jphysiol_2010_200733
crossref_primary_10_1113_jphysiol_2010_200733
wiley_primary_10_1113_jphysiol_2010_200733_TJP4374
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-03-15
PublicationDateYYYYMMDD 2011-03-15
PublicationDate_xml – month: 03
  year: 2011
  text: 2011-03-15
  day: 15
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
– name: London
PublicationTitle The Journal of physiology
PublicationTitleAlternate J Physiol
PublicationYear 2011
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Blackwell Science Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
– name: Blackwell Science Inc
References 2004; 63
2010; 53
2010; 2010
1997; 82
2002; 72
2004; 89
2007; 92
2009; 174
2004; 1
2009; 119
2007; 14
2007; 28
2006; 86
2007; 358
1994; 368
2005; 563
2000; 104
1994; 180
1989; 264
2003; 24
1988; 177
2001; 15
2000; 165
2008; 88
2009; 107
2001; 537
2007; 21
2008; 295
2010; 51
2010; 9
2003; 88
e_1_2_6_32_1
e_1_2_6_10_1
e_1_2_6_31_1
e_1_2_6_30_1
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_11_1
e_1_2_6_12_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_21_1
e_1_2_6_20_1
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_29_1
Le Y (e_1_2_6_16_1) 2004; 1
e_1_2_6_28_1
e_1_2_6_27_1
e_1_2_6_26_1
15531514 - J Clin Endocrinol Metab. 2004 Nov;89(11):5577-82
11731593 - J Physiol. 2001 Dec 1;537(Pt 2):633-9
15618276 - J Physiol. 2005 Mar 1;563(Pt 2):507-16
20621720 - Cytokine. 2010 Aug;51(2):195-201
20631206 - Mol Cell Proteomics. 2010 Nov;9(11):2482-96
19451693 - J Clin Invest. 2009 Jun;119(6):1571-82
19095949 - Am J Pathol. 2009 Jan;174(1):164-76
3263918 - Eur J Biochem. 1988 Nov 1;177(2):357-61
20224659 - J Biomed Biotechnol. 2010;2010:520258
14609022 - J Muscle Res Cell Motil. 2003;24(2-3):113-9
8127368 - Nature. 1994 Mar 24;368(6469):339-42
17331593 - Trends Pharmacol Sci. 2007 Apr;28(4):152-6
J Physiol. 2012 Dec 15;590(Pt 24):6425
7964481 - J Exp Med. 1994 Dec 1;180(6):2039-48
17030560 - Exp Physiol. 2007 Jan;92(1):233-40
18780777 - Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1191-204
11687509 - FASEB J. 2001 Dec;15(14):2748-50
11046061 - J Immunol. 2000 Nov 1;165(9):5269-77
10683519 - J Neuroimmunol. 2000 Apr 3;104(1):92-7
17410179 - Gene Ther. 2007 Jun;14(12):950-9
20195842 - Diabetologia. 2010 Jun;53(6):1131-41
16996102 - Virology. 2007 Feb 5;358(1):98-108
16212895 - Cell Mol Immunol. 2004 Apr;1(2):95-104
18923185 - Physiol Rev. 2008 Oct;88(4):1379-406
12101257 - J Leukoc Biol. 2002 Jul;72(1):9-18
2917992 - J Biol Chem. 1989 Mar 5;264(7):4133-7
16715102 - Lab Invest. 2006 Aug;86(8):800-14
15294041 - Proc Nutr Soc. 2004 May;63(2):263-7
19850730 - J Appl Physiol (1985). 2009 Dec;107(6):1830-9
9134917 - J Appl Physiol (1985). 1997 May;82(5):1662-7
17227950 - FASEB J. 2007 Apr;21(4):1026-36
12843134 - J Clin Endocrinol Metab. 2003 Jul;88(7):3005-10
References_xml – volume: 174
  start-page: 164
  year: 2009
  end-page: 176
  article-title: Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1
  publication-title: Am J Pathol
– volume: 563
  start-page: 507
  year: 2005
  end-page: 516
  article-title: Exercise induces interleukin‐8 expression in human skeletal muscle
  publication-title: J Physiol
– volume: 368
  start-page: 339
  year: 1994
  end-page: 342
  article-title: Impaired immune and acute‐phase responses in interleukin‐6‐deficient mice
  publication-title: Nature
– volume: 24
  start-page: 113
  year: 2003
  end-page: 119
  article-title: Searching for the exercise factor: is IL‐6 a candidate?
  publication-title: J Muscle Res Cell Motil
– volume: 107
  start-page: 1830
  year: 2009
  end-page: 1839
  article-title: Control of gluconeogenic genes during intense/prolonged exercise: hormone‐independent effect of muscle‐derived IL‐6 on hepatic tissue and PEPCK mRNA
  publication-title: J Appl Physiol
– volume: 537
  start-page: 633
  year: 2001
  end-page: 639
  article-title: Interleukin‐6 production in contracting human skeletal muscle is influenced by pre‐exercise muscle glycogen content
  publication-title: J Physiol
– volume: 92
  start-page: 233
  year: 2007
  end-page: 240
  article-title: Exercise induces interleukin‐8 receptor. (CXCR2) expression in human skeletal muscle
  publication-title: Exp Physiol
– volume: 358
  start-page: 98
  year: 2007
  end-page: 108
  article-title: Induction of the CXCL1 (KC) chemokine in mouse astrocytes by infection with the murine encephalomyelitis virus of Theiler
  publication-title: Virology
– volume: 89
  start-page: 5577
  year: 2004
  end-page: 5582
  article-title: Interleukin‐6 regulates human adipose tissue lipid metabolism and leptin production
  publication-title: J Clin Endocrinol Metab
– volume: 63
  start-page: 263
  year: 2004
  end-page: 267
  article-title: The metabolic role of IL‐6 produced during exercise: is IL‐6 an exercise factor?
  publication-title: Proc Nutr Soc
– volume: 72
  start-page: 9
  year: 2002
  end-page: 18
  article-title: Role of CXCL1 in tumorigenesis of melanoma
  publication-title: J Leukoc Biol
– volume: 86
  start-page: 800
  year: 2006
  end-page: 814
  article-title: Cytokine‐induced neutrophil chemoattractant‐1 is released by the noninjured liver in a rat acute‐phase model
  publication-title: Lab Invest
– volume: 21
  start-page: 1026
  year: 2007
  end-page: 1036
  article-title: Enhanced CXCL1 production and angiogenesis in adenosine‐mediated lung disease
  publication-title: FASEB J
– volume: 14
  start-page: 950
  year: 2007
  end-page: 959
  article-title: Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation
  publication-title: Gene Ther
– volume: 15
  start-page: 2748
  year: 2001
  end-page: 2750
  article-title: Transcriptional activation of the IL‐6 gene in human contracting skeletal muscle: influence of muscle glycogen content
  publication-title: FASEB J
– volume: 295
  start-page: E1191
  year: 2008
  end-page: E1204
  article-title: Contractile C2C12 myotube model for studying exercise‐inducible responses in skeletal muscle
  publication-title: Am J Physiol Endocrinol Metab
– volume: 104
  start-page: 92
  year: 2000
  end-page: 97
  article-title: Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis
  publication-title: J Neuroimmunol
– volume: 264
  start-page: 4133
  year: 1989
  end-page: 4137
  article-title: The platelet‐derived growth factor‐inducible KC gene encodes a secretory protein related to platelet α‐granule proteins
  publication-title: J Biol Chem
– volume: 177
  start-page: 357
  year: 1988
  end-page: 361
  article-title: Plasma clearance, organ distribution and target cells of interleukin‐6/hepatocyte‐stimulating factor in the rat
  publication-title: Eur J Biochem
– volume: 53
  start-page: 1131
  year: 2010
  end-page: 1141
  article-title: Activation of the mitogen‐activated protein kinase (MAPK) signalling pathway in the liver of mice is related to plasma glucose levels after acute exercise
  publication-title: Diabetologia
– volume: 82
  start-page: 1662
  year: 1997
  end-page: 1667
  article-title: Carbohydrate and the cytokine response to 2.5 h of running
  publication-title: J Appl Physiol
– volume: 9
  start-page: 2482
  year: 2010
  end-page: 2496
  article-title: Dynamics of the skeletal muscle secretome during myoblast differentiation
  publication-title: Mol Cell Proteomics
– volume: 2010
  start-page: 520258
  year: 2010
  article-title: The role of exercise‐induced myokines in muscle homeostasis and the defense against chronic diseases
  publication-title: J Biomed Biotechnol
– volume: 180
  start-page: 2039
  year: 1994
  end-page: 2048
  article-title: Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells
  publication-title: J Exp Med
– volume: 88
  start-page: 1379
  year: 2008
  end-page: 1406
  article-title: Muscle as an endocrine organ: focus on muscle‐derived interleukin‐6
  publication-title: Physiol Rev
– volume: 1
  start-page: 95
  year: 2004
  end-page: 104
  article-title: Chemokines and chemokine receptors: their manifold roles in homeostasis and disease
  publication-title: Cell Mol Immunol
– volume: 51
  start-page: 195
  year: 2010
  end-page: 201
  article-title: Autocrine IL‐6 regulates GRO‐α production in thymic epithelial cells
  publication-title: Cytokine
– volume: 119
  start-page: 1571
  year: 2009
  end-page: 1582
  article-title: Abrogation of TGF‐β signaling enhances chemokine production and correlates with prognosis in human breast cancer
  publication-title: J Clin Invest
– volume: 88
  start-page: 3005
  year: 2003
  end-page: 3010
  article-title: Interleukin‐6 stimulates lipolysis and fat oxidation in humans
  publication-title: J Clin Endocrinol Metab
– volume: 165
  start-page: 5269
  year: 2000
  end-page: 5277
  article-title: The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR CXC chemokine‐induced angiogenic activity
  publication-title: J Immunol
– volume: 28
  start-page: 152
  year: 2007
  end-page: 156
  article-title: Beneficial health effects of exercise – the role of IL‐6 as a myokine
  publication-title: Trends Pharmacol Sci
– ident: e_1_2_6_31_1
  doi: 10.1016/j.cyto.2010.05.002
– ident: e_1_2_6_32_1
  doi: 10.1210/jc.2002-021687
– ident: e_1_2_6_9_1
  doi: 10.1189/jlb.72.1.9
– ident: e_1_2_6_21_1
  doi: 10.2353/ajpath.2009.080350
– ident: e_1_2_6_25_1
  doi: 10.1023/A:1026070911202
– ident: e_1_2_6_4_1
  doi: 10.1016/S0165-5728(99)00266-0
– ident: e_1_2_6_18_1
  doi: 10.1096/fj.06-7301com
– ident: e_1_2_6_14_1
  doi: 10.1096/fj.01-0507fje
– ident: e_1_2_6_28_1
  doi: 10.1038/labinvest.3700435
– ident: e_1_2_6_20_1
  doi: 10.1152/jappl.1997.82.5.1662
– ident: e_1_2_6_23_1
  doi: 10.1152/physrev.90100.2007
– ident: e_1_2_6_3_1
  doi: 10.1113/jphysiol.2004.077610
– ident: e_1_2_6_26_1
  doi: 10.1079/PNS2004338
– ident: e_1_2_6_12_1
  doi: 10.1007/s00125-010-1666-3
– volume: 1
  start-page: 95
  year: 2004
  ident: e_1_2_6_16_1
  article-title: Chemokines and chemokine receptors: their manifold roles in homeostasis and disease
  publication-title: Cell Mol Immunol
– ident: e_1_2_6_7_1
  doi: 10.1155/2010/520258
– ident: e_1_2_6_17_1
  doi: 10.1084/jem.180.6.2039
– ident: e_1_2_6_19_1
  doi: 10.1152/ajpendo.90280.2008
– ident: e_1_2_6_5_1
  doi: 10.1152/japplphysiol.00739.2009
– ident: e_1_2_6_10_1
  doi: 10.1113/expphysiol.2006.034769
– ident: e_1_2_6_11_1
  doi: 10.1074/mcp.M110.002113
– ident: e_1_2_6_15_1
  doi: 10.1038/368339a0
– ident: e_1_2_6_8_1
  doi: 10.1111/j.1432-1033.1988.tb14383.x
– ident: e_1_2_6_24_1
  doi: 10.1016/j.tips.2007.02.002
– ident: e_1_2_6_13_1
  doi: 10.1038/sj.gt.3302951
– ident: e_1_2_6_27_1
  doi: 10.1016/j.virol.2006.08.003
– ident: e_1_2_6_22_1
  doi: 10.1016/S0021-9258(19)84972-4
– ident: e_1_2_6_2_1
  doi: 10.4049/jimmunol.165.9.5269
– ident: e_1_2_6_29_1
  doi: 10.1111/j.1469-7793.2001.00633.x
– ident: e_1_2_6_30_1
  doi: 10.1210/jc.2004-0603
– ident: e_1_2_6_6_1
  doi: 10.1172/JCI37480
– reference: 20224659 - J Biomed Biotechnol. 2010;2010:520258
– reference: 19850730 - J Appl Physiol (1985). 2009 Dec;107(6):1830-9
– reference: 18780777 - Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1191-204
– reference: 15618276 - J Physiol. 2005 Mar 1;563(Pt 2):507-16
– reference: 17331593 - Trends Pharmacol Sci. 2007 Apr;28(4):152-6
– reference: 15531514 - J Clin Endocrinol Metab. 2004 Nov;89(11):5577-82
– reference: 9134917 - J Appl Physiol (1985). 1997 May;82(5):1662-7
– reference: 14609022 - J Muscle Res Cell Motil. 2003;24(2-3):113-9
– reference: 17410179 - Gene Ther. 2007 Jun;14(12):950-9
– reference: 17030560 - Exp Physiol. 2007 Jan;92(1):233-40
– reference: 20631206 - Mol Cell Proteomics. 2010 Nov;9(11):2482-96
– reference: 19095949 - Am J Pathol. 2009 Jan;174(1):164-76
– reference: 17227950 - FASEB J. 2007 Apr;21(4):1026-36
– reference: 11731593 - J Physiol. 2001 Dec 1;537(Pt 2):633-9
– reference: 10683519 - J Neuroimmunol. 2000 Apr 3;104(1):92-7
– reference: 18923185 - Physiol Rev. 2008 Oct;88(4):1379-406
– reference: 12843134 - J Clin Endocrinol Metab. 2003 Jul;88(7):3005-10
– reference: 2917992 - J Biol Chem. 1989 Mar 5;264(7):4133-7
– reference: 19451693 - J Clin Invest. 2009 Jun;119(6):1571-82
– reference: 3263918 - Eur J Biochem. 1988 Nov 1;177(2):357-61
– reference: 16996102 - Virology. 2007 Feb 5;358(1):98-108
– reference: 11687509 - FASEB J. 2001 Dec;15(14):2748-50
– reference: 8127368 - Nature. 1994 Mar 24;368(6469):339-42
– reference: 11046061 - J Immunol. 2000 Nov 1;165(9):5269-77
– reference: 12101257 - J Leukoc Biol. 2002 Jul;72(1):9-18
– reference: 20195842 - Diabetologia. 2010 Jun;53(6):1131-41
– reference: 16715102 - Lab Invest. 2006 Aug;86(8):800-14
– reference: 15294041 - Proc Nutr Soc. 2004 May;63(2):263-7
– reference: 7964481 - J Exp Med. 1994 Dec 1;180(6):2039-48
– reference: 16212895 - Cell Mol Immunol. 2004 Apr;1(2):95-104
– reference: 20621720 - Cytokine. 2010 Aug;51(2):195-201
– reference: - J Physiol. 2012 Dec 15;590(Pt 24):6425
SSID ssj0013099
Score 2.2397184
Snippet Non‐technical summary  Exercise is known to stimulate the production of various exercise factors including the well‐described muscle‐derived interleukin‐6...
Non‐technical summary  Exercise is known to stimulate the production of various exercise factors including the well‐described muscle‐derived interleukin‐6...
The chemokine CXC ligand-1 (CXCL-1) is a small cytokine that elicits effects by signalling through the chemokine receptor CXCR2. CXCL-1 has neutrophil...
Non-technical summary Exercise is known to stimulate the production of various exercise factors including the well-described muscle-derived interleukin-6...
The aim of this study was to unravel the mechanisms whereby CXCL-1 is regulated by exercise in mice. After a single bout of exercise, CXCL-1 protein increased...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1409
SubjectTerms Animal subjects
Animals
Blood
Chemokine CXCL1 - biosynthesis
Chemokines
Chemokines - biosynthesis
Cytokines
Exercise physiology
Exercise Test - methods
Fasting - metabolism
Gene Expression Regulation
Inflammation
Interleukin-6 - biosynthesis
Knowledge
Liver
Liver - metabolism
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Muscle, Skeletal - metabolism
Muscles (exercise effects)
Physical Conditioning, Animal - methods
Physical Exertion - physiology
Rodents
Skeletal Muscle and Exercise
Title Exercise‐induced liver chemokine CXCL‐1 expression is linked to muscle‐derived interleukin‐6 expression
URI https://onlinelibrary.wiley.com/doi/abs/10.1113%2Fjphysiol.2010.200733
https://www.ncbi.nlm.nih.gov/pubmed/21224226
https://www.proquest.com/docview/1545333988
https://www.proquest.com/docview/1022560221
https://www.proquest.com/docview/862004322
https://pubmed.ncbi.nlm.nih.gov/PMC3082100
Volume 589
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5VPXHhVR4ppTIS4ubi-JE4x2rVVVUBqlAr7S1K7LiU7iaou0GUEz-B38gvYRwnoUtBILjaM0lszzjf2OPPAM-1MsYmTlLhYkOlyhzNnGI0xUJE-4VNtT_v_PpNcngqj2ZqtgHT4SxM4IcYF9y8Z3TztXfwouxvIYk92cD7LvRv5iE9i3e3D-JU7NO2PDZ6y39sJrAsG0nDUxX3J-jwMS9_9ZD1P9QN2Hkze_I6qu1-S9M7cDY0KGSjXOy1q3LPfP6J6_H_W3wXbvfIlewHU7sHG1V9H7b2a4zaF1fkBTkOas3Z1RY0B_1NTt--fMWgH83HkrnPACFoI4vmAj-FTGaTV1gdk-pTn4xbk_Ml8TvKKL1qyKJd4otQxKKXfMQyT21xOa9aVMfS5JriAzidHpxMDml_tQM1iHgk5aW2JjbWCWmUUcxpoXXhEonRo2WiSJKUe2pBqxBCFFKkrNBCOFtJZqR1TDyEzbqpq8dALC-5qHyYhP5eKlGaonK8LJmMbSp0EYEYhjM3Pe-5v35jnof4R-RDv-a-X_PQrxHQUetD4P34g_zOYCl5Pwsscw9PhRCZ1hE8G6vRf_2mTFFXTYsyaJWIOjmPIyC_kcGos6NO5BE8CrY3fhP3O6MIoSNI16xyFPD04es19fm7jkbcExXFjEXAO6P7q2bmJ0fHOBpy-1-UnsCtsCIvaKx2YHN12VZPEdKtyt3OYXe7tbbv9n5Now
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6VcoALr_IIFDAS4pbi-JF4j9WqZSnbqkJbaW9RYse0dDdB3Q2inPgJ_EZ-CeM4CV0KAiGu9kwSOzPJN_b4G4DnSmptYitCbiMdCjmw4cBKGibYiGg_M4ly5533D-LRkdibyukavOrOwnh-iH7BzXlG8712Du4WpFsvd2wD75vYv5r5_CzWlB-8Alddce8mtnrLfmwn0MGgpw1PZNSeocPrvPzVVVb_UZeA5-X8yYu4tvkx7d6E425IPh_ldKte5lv6809sj_9hzLfgRgteyba3ttuwVpR3YGO7xMB9fk5ekEOvVr0734Bqpy3m9O3LV4z70YIMmbkkEIJmMq9O8VnIcDocY3dEik9tPm5JThbEbSqj9LIi83qBN0IRg47yEdscu8XZrKhRHVvjC4p34Wh3ZzIchW11h1Aj6BEhy5XRkTaWCy21pFZxpTIbCwwgDeVZHCfMsQsaiSgiEzyhmeLcmkJQLYyl_B6sl1VZPABiWM544SIldPlc8lxnhWV5TkVkEq6yAHj3PlPdUp-7Chyz1IdAPO3mNXXzmvp5DSDstT546o8_yG92ppK2H4JF6hAq53ygVADP-m50Ybcvk5VFVaMMmiUCT8aiAMhvZDDwbNgTWQD3vfH1z8Tc5iii6ACSFbPsBRyD-GpPeXLcMIk7rqKI0gBYY3V_Ncx0sneIb0M8_Belp3BtNNkfp-PXB28ewXW_QM_DSG7C-vKsLh4jwlvmTxrv_Q6uIlCu
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VIiEuvMojUMBIiFuK40fiPVbbrkop1Qq10t6ixI7b0t2k6m4Q5cRP4DfySxjHSehSEAiu9kwSOzP2N_b4M8BLJbU2sRUht5EOhRzYcGAlDRMsRLSfmUS5887v9uOdQ7E7kZMVGHVnYTw_RL_g5jyjGa-dg58Z2zq5Ixv40IT-1dSnZ7Hm9sFrcF3EVDnr3nrPfuwm0MGgZw1PZNQeocPnvP7VU5anqCu482r65GVY28xLo9tw1LXIp6OcbtSLfEN__ons8f-bfAdutdCVbHpbuwsrRXkP1jZLDNtnF-QVGXu16uhiDart9iqnb1--YtSP9mPI1KWAEDSSWXWKn0KGk-EeVkek-NRm45bkZE7cljJKLyoyq-f4IhQx6CYfscxxW5xPixrVsTS-pHgfDkfbB8OdsL3bIdQIeUTIcmV0pI3lQkstqVVcqczGAsNHQ3kWxwlz3IJGIobIBE9opji3phBUC2MpfwCrZVUWj4AYljNeuDgJHT6XPNdZYVmeUxGZhKssAN79zlS3xOfu_o1p6gMgnnb9mrp-TX2_BhD2Wmee-OMP8uudpaTtMDBPHT7lnA-UCuBFX40O7HZlsrKoapRBq0TYyVgUAPmNDIadDXciC-Cht73-m5jbGkUMHUCyZJW9gOMPX64pT44bHnHHVBRRGgBrjO6vmpke7I7xb4jH_6L0HG6Mt0bp3pv9t0_gpl-d52Ek12F1cV4XTxHeLfJnje9-B7I5T2Y
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exercise-induced+liver+chemokine+CXCL-1+expression+is+linked+to+muscle-derived+interleukin-6+expression&rft.jtitle=The+Journal+of+physiology&rft.au=Pedersen%2C+Line&rft.au=Pilegaard%2C+Henriette&rft.au=Hansen%2C+Jakob&rft.au=Brandt%2C+Claus&rft.date=2011-03-15&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0022-3751&rft.eissn=1469-7793&rft.volume=589&rft.issue=6&rft.spage=1409&rft_id=info:doi/10.1113%2Fjphysiol.2010.200733&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3374326911
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3751&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3751&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3751&client=summon